YOU ARE IN
Future encryption technologies will adopt new authentication schemes for better personal identity protection. This will provide a private person the ability to be in more CONTROL of their data privacy and intellectual property rights.
As a thought leader in cutting-edge technologies such as AI, blockchain, authentication, quantum, and data security, I spearhead an innovative technology advisory firm that also offers asset management and IP valuation & financing services. Our independent IP valuation services empower forward-thinking companies to gain a competitive edge, attract attention from capital markets, bolster share prices, and secure funding opportunities. We achieve this by leveraging non-dilutive financing options that effectively communicate the marketability strength and value of their intellectual property assets.
Additionally, I hold the position of senior managing partner at a pioneering technology incubation accelerator that focuses on growth opportunities in emerging deep technology markets. Our primary objective is to mitigate the risks of data privacy and data rights breaches. Over the years, I have authored pivotal patents in network security, identity verification, content security, and network tracking/use verification.
Furthermore, I actively contribute to the United Nations (UN) AI for Good Innovation Factory project, where I serve as a judge, expert, and speaker. Through live pitch sessions, we support deep tech start-ups in accelerating the UN's Sustainable Development Goals (SDGs). Additionally, I am proud to be an official member of the Forbes Finance Council, an exclusive community for senior-level finance executives.
Before delving into the world of deep technology and data security, I held key executive management positions at renowned Fortune 500 companies, including Kaiser Permanente, 3M, GSK, Allergan, and KPMG. With a track record of over 20 years in entrepreneurship, technology, global operations management, and business development, my expertise has been predominantly within the Healthcare and Life Sciences industry.